Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.890
-0.020 (-1.05%)
At close: Sep 18, 2026, 4:00 PM EDT
1.900
+0.010 (0.53%)
After-hours: Sep 18, 2026, 4:10 PM EDT
Innate Pharma Employees
Innate Pharma had 164 employees as of December 31, 2025. The number of employees decreased by 17 or -9.39% compared to the previous year.
Employees
164
Change
-17
Growth
-9.39%
Revenue / Employee
$68,325
Profits / Employee
-$330,590
Market Cap
173.61M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 164 | -17 | -9.39% |
| Jun 30, 2025 | 174 | - | - |
| Dec 31, 2024 | 181 | 2 | 1.12% |
| Dec 31, 2023 | 179 | -32 | -15.17% |
| Dec 31, 2022 | 211 | -4 | -1.86% |
| Dec 31, 2021 | 215 | -29 | -11.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Molecular Partners AG | 134 |
| MediWound | 121 |
| Precision BioSciences | 67 |
| Neumora Therapeutics | 63 |
| Armata Pharmaceuticals | 61 |
| Jyong Biotech | 27 |
| Spruce Biosciences | 22 |
| Outlook Therapeutics | 17 |
IPHA News
- 18 hours ago - Innate Pharma (IPHA) Q2 2026 Earnings Call Transcript - The Motley Fool
- 1 day ago - Innate Pharma Q2 Earnings Call Highlights - MarketBeat
- 1 day ago - Innate Pharma Earnings Call Transcript: Q2 2026 - Transcripts
- 1 day ago - Innate Pharma Earnings release: Q2 2026 - Filings
- 1 day ago - Innate Pharma Earnings release: Q2 2026 - Filings
- 1 day ago - Innate Pharma SA: Innate Pharma Reports First Half 2026 Business Update and Financial Results - Finanz Nachrichten
- 1 day ago - Innate Pharma Reports First Half 2026 Business Update and Financial Results - Wallstreet:Online
- 1 day ago - Innate Pharma Reports First Half 2026 Business Update and Financial Results - Business Wire